Senior insider sale
PUMA BIOTECHNOLOGY, INC. — senior position signals high conviction
$84.3K
11.61K shares
What this filing means
DORVAL ALLISON plans to sell 11.61K shares of PUMA BIOTECHNOLOGY, INC. valued at approximately $84.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/12/2026ACC: 0001959173-26-004588
11.61K
Shares to sell
$84.3K
Approx. market value
11.61K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
6/11/2026
11.61KTotal acquired11.61K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/11/2026 | Restricted Stock Vesting Compensation | 11.61K | — |
| Total | 11.61K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
11.61K
Market value
$84.3K
6/12/2026
Total
Units
11.61K
Value
$84.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/12/2026 | 11.61K | $84.3K | NASDAQ | Planned |
| Total | 11.61K | $84.3K | ||